| Reducing Risk Of Renal Failure In Obese Patients - RedOrbit |
|
|
RedOrbit ... (ACE) inhibitor drug, ramipril, is particularly effective in lowering the risk of end-stage renal disease (ESRD) in obese patients, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). |